blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability
Register Forum

2022.02.11

More...
blank News flashes

News flashes

New version of the European Patent Register - SPC information for Unitary Patents.

2024-03-06

More...
blank Related links

Extract from the Register of European Patents

EP About this file: EP4221727

EP4221727 - DONOR HEMATOPOIETIC CELL CHIMERISM AND ORGAN AND TISSUE TRANSPLANTATION AND AUTOIMMUNE TOLERANCE [Right-click to bookmark this link]
StatusRequest for examination was made
Status updated on  07.07.2023
Database last updated on 16.07.2024
FormerThe international publication has been made
Status updated on  08.04.2022
Most recent event   Tooltip01.12.2023Change: Validation statespublished on 03.01.2024  [2024/01]
01.12.2023Change - extension statespublished on 03.01.2024  [2024/01]
Applicant(s)For all designated states
The Board of Trustees of the Leland Stanford Junior University
Office of the General Counsel
Building 170, Third Floor, Main Quad
P.O. Box 20386
Stanford, CA 94305-2038 / US
[2023/32]
Inventor(s)01 / LOWSKY, Robert
Stanford, California 94305 / US
02 / STROBER, Samuel
Portola Valley, California 94028 / US
03 / MEYER, Everett Hurteau
Belmont, California 94002 / US
04 / JENSEN, Kent
Redwood City, California 94063 / US
05 / BUSQUE, Stephan
Stanford, California 94305 / US
 [2023/32]
Representative(s)Mewburn Ellis LLP
Aurora Building
Counterslip
Bristol BS1 6BX / GB
[2023/32]
Application number, filing date21876282.128.09.2021
[2023/32]
WO2021US52346
Priority number, dateUS202063085717P30.09.2020         Original published format: US 202063085717 P
[2023/32]
Filing languageEN
Procedural languageEN
PublicationType: A1 Application with search report
No.:WO2022072320
Date:07.04.2022
Language:EN
[2022/14]
Type: A1 Application with search report 
No.:EP4221727
Date:09.08.2023
Language:EN
The application published by WIPO in one of the EPO official languages on 07.04.2022 takes the place of the publication of the European patent application.
[2023/32]
Search report(s)International search report - published on:US07.04.2022
ClassificationIPC:A61K35/28, C12N5/074, A61N5/10, A61K35/17, C12N5/0783
[2023/32]
CPC:
A61K35/28 (EP,US); A61K39/4611 (EP,US); A61K39/4621 (EP);
A61K39/4631 (EP); A61K39/46433 (EP); A61K39/46434 (EP);
A61N5/10 (EP,US); A61K2035/124 (US) (-)
Designated contracting statesAL,   AT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HR,   HU,   IE,   IS,   IT,   LI,   LT,   LU,   LV,   MC,   MK,   MT,   NL,   NO,   PL,   PT,   RO,   RS,   SE,   SI,   SK,   SM,   TR [2023/32]
TitleGerman:HÄMATOPOIETISCHE DONORZELLEN-CHIMÄRISMUS UND ORGAN- UND GEWEBETRANSPLANTATION UND AUTOIMMUNTOLERANZ[2023/32]
English:DONOR HEMATOPOIETIC CELL CHIMERISM AND ORGAN AND TISSUE TRANSPLANTATION AND AUTOIMMUNE TOLERANCE[2023/32]
French:CHIMÉRISME DE CELLULES HÉMATOPOÏÉTIQUES DONNEUSES ET TRANSPLANTATION D'ORGANE ET DE TISSU ET TOLÉRANCE AUTO-IMMUNE[2023/32]
Entry into regional phase09.03.2023National basic fee paid 
09.03.2023Search fee paid 
09.03.2023Designation fee(s) paid 
09.03.2023Examination fee paid 
Examination procedure09.03.2023Examination requested  [2023/32]
10.11.2023Amendment by applicant (claims and/or description)
Fees paidRenewal fee
18.09.2023Renewal fee patent year 03
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court
See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Cited inInternational search[Y]US2019151362  (LI ZONGHAI [CN], et al) [Y] 1-3 * para [0148], [0150]. [0152], [0194) *;
 [XY]US2020254015  (STROBER SAMUEL [US], et al) [X] 22-23, 30-31 * para [0002], [0010], [0030], [0033], [0054], [0071], [0076], [0079] * [Y] 1-3, 24-26;
 [Y]  - BLEAKLEY et al., "Engineering Human Peripheral Blood Stem Cell Grafts that Are Depleted of Naive T Cells and Retain Functional Pathogen-Specific Memory T Cells", ScienceDirect, (20140500), vol. 20, no. 5, doi:10.1016/j.bbmt.2014.01.032, pages 705 - 716, XP028844980 [Y] 24-26 * . Abstract; pg 705, col 1, para 2 - col 2, para 1-2; pg 706, col 1, para 1 *

DOI:   http://dx.doi.org/10.1016/j.bbmt.2014.01.032
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.